Should We Measure Quality by the Dose?
نویسندگان
چکیده
منابع مشابه
Should We Consider another Booster Dose of Measles Vaccine?
Background: To date, 36 years has passed since the beginning of measles vaccination; the disease is still circulating around the world, threatening lives of human beings especially in developing countries. In recent years, we have confronted measles in previously vaccinated adults from all over the country. Objective: To find out if there is a need for changing our routine measles vaccination ...
متن کاملMeasuring surgical quality: which measure should we trust?
curve and technical problems with implementation early in use. Surveys show that physicians and staffmembers believe that theAWS improvescommunication, teamengagement,patient safety, and compliancewith Surgical Care Improvement Project measures. Future goals for the AWS at our facility include tracking nearmisses to improve patient safety and staff educationopportunities,developingastructuredfe...
متن کاملHow should we measure the ciliary muscle?
In an in vivo analysis of ciliary muscle morphologic changes with accommodation and axial ametropia by Sheppard and Davies, the authors state that “There is a paucity of literature documenting in vivo changes in human ciliary muscle biometry with accommodation.” I agree with the authors, and they should be commended for tackling a wanting area of scientific investigation. Subsequently, the auth...
متن کاملBlood doping by cobalt. Should we measure cobalt in athletes?
BACKGROUND Blood doping is commonplace in competitive athletes who seek to enhance their aerobic performances through illicit techniques. PRESENTATION OF THE HYPOTHESIS Cobalt, a naturally-occurring element with properties similar to those of iron and nickel, induces a marked and stable polycythemic response through a more efficient transcription of the erythropoietin gene. TESTING THE HYPO...
متن کاملWhen should we measure lipoprotein (a)?
Recently published epidemiological and genetic studies strongly suggest a causal relationship of elevated concentrations of lipoprotein (a) [Lp(a)] with cardiovascular disease (CVD), independent of low-density lipoproteins (LDLs), reduced high density lipoproteins (HDL), and other traditional CVD risk factors. The atherogenicity of Lp(a) at a molecular and cellular level is caused by interferen...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the American College of Cardiology
سال: 2013
ISSN: 0735-1097
DOI: 10.1016/j.jacc.2013.07.059